Hier finden Sie die Publikationen der AG Fuchs.

Sie befinden sich hier:

Please find here all publications that are available via PubMed

List of all publications

Publikationen 01-10

  • C. Bhargava, H. Dürkop, X. Zhao, A. Weng, M. F. Melzig, H. Fuchs. Targeted dianthin is a powerful toxin to treat pancreatic carcinoma when applied in combination with the glycosylated triterpene SO1861. Mol Oncol. 11(11):1527–1543 (2017)
  • R. Gilabert-Oriol, S. G. B. Furness, B. W. Stringer, A. Weng, H. Fuchs, B. W. Day, A. Kourakis, A. W. Boyd, D. L. Hare, M. Thakur, T. G. Johns, P. J. Wookey. Dianthin-30 or gelonin versus monomethyl auristatin E, each configured with an anti-calcitonin receptor antibody, are differentially potent in vitro in high grade glioma cell lines derived from Glioblastoma Cancer Immunol. Immunother. 66(9):1217–1228 (2017)
  • R. Gilabert-Oriol, M. Thakur, K. Haussmann, N. Niesler, C. Bhargava, C. Görick, H. Fuchs, A. Weng. Saponins from Saponaria officinalis L. Augment the Efficacy of a Rituximab-Immunotoxin. Planta Med. 82(18):1525–1531 (2016)
  • R. Gilabert-Oriol, A. Weng, A. Trautner, C. Weise, D. Schmid, C. Bhargava, N. Niesler, P. J. Wookey, H. Fuchs, M. Thakur. Combinatorial approach to increase efficacy of Cetuximab, Panitumumab and Trastuzumab by dianthin conjugation and co-application of SO1861. Biochem Pharmacol. 97(3):247–255 (2015)
  • R. Gilabert-Oriol, A. Weng, B. von Mallinckrodt, A. Stöshel, L. Nissi, M. F. Melzig, H. Fuchs, M. Thakur. Electrophoretic mobility as a tool to separate immune adjuvant saponins from Quillaja saponaria Molina. Int. J. Pharm. 487:39–48 (2015)
  • S. E. Holmes, C. Bachran, H. Fuchs, A. Weng, M. F. Melzig, S. U. Flavell, D. J. Flavell. Triterpenoid saponin augmentation of saporin-based immunotoxin cytotoxicity for human leukaemia and lymphoma cells is partially immunospecific and target molecule dependent. Immunopharmacol Immunotoxicol. 37(1):42–55 (2015)
  • B. von Mallinckrodt, M. Thakur, A. Weng, R. Gilabert-Oriol, H. Dürkop, W. Brenner, M. Lukas, N. Beindorff, M. F. Melzig, H. Fuchs. Dianthin-EGF is an effective tumor targeted toxin in combination with saponins in a xenograft model for colon carcinoma. Future Oncol. 10(14):2161–2175 (2014)
  • R. Gilabert-Oriol, M. Thakur, B. von Mallinckrodt, C. Bhargava, B. Wiesner, J. Eichhorst, M. F. Melzig, H. Fuchs, A. Weng. Reporter assay for endo/lysosomal escape of toxin-based therapeutics. Toxins (Basel) 6(5):1644–1666 (2014)
  • M. Thakur, G. Jerz, D. Tuwalska, R. Gilabert-Oriol, S. Wybraniec, P. Winterhalter, H. Fuchs, A. Weng. High-speed countercurrent chromatographic recovery and off-line electrospray ionization mass spectrometry profiling of bisdesmodic saponins from Saponaria officinalis possessing synergistic toxicity enhancing properties on targeted antitumor toxins. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 955–956:1–9 (2014)
  • R. Gilabert-Oriol, M. Thakur, B. von Mallinckrodt, T. Hug, B. Wiesner, J. Eichhorst, M. F. Melzig, H. Fuchs, A. Weng. Modified trastuzumab and cetuximab mediate efficient toxin delivery while retaining antibodydependent cell-mediated cytotoxicity in target cells. Mol. Pharm. 10(11):4347–4357 (2013)

Publikationen 11-20

  • R. Gilabert-Oriol, M. Thakur, C. Weise, J. Dernedde, B. von Mallinckrodt, H. Fuchs, A. Weng. Small structural differences of targeted anti-tumor toxins result in strong variation of protein expression. Protein Expr. Purif. 91(1):54–60 (2013)
  • R. Gilabert-Oriol, K. Mergel, M. Thakur, B. von Mallinckrodt, M. F. Melzig, H. Fuchs, Weng A. Real-time analysis of membrane permeabilizing effects of oleanane saponins. Bioorg Med Chem. 21(8):2387–2395 (2013)
  • M. Thakur, A. Weng, A. Pieper, K. Mergel, B. von Mallinckrodt, R. Gilabert-Oriol, C. Görick, B. Wiesner, J. Eichhorst, M. F. Melzig, H. Fuchs. Macromolecular interactions of triterpenoids and targeted toxins: Role of saponins charge. Int. J. Biol. Macromol. 61C:285–294 (2013)
  • C. Zahn, M. Kaup, R. Fluhrer, H. Fuchs. The transferrin receptor-1 membrane stub undergoes intramembrane proteolysis by signal peptide peptidase-like 2b. FEBS J. 280(7):1653–1663 (2013)
  • M. Thakur, K. Mergel, A. Weng, B. von Mallinckrodt, R. Gilabert-Oriol, H. Dürkop, M. F. Melzig, H. Fuchs. Targeted tumor therapy by epidermal growth factor appended toxin and purified saponin: an evaluation of toxicity and therapeutic potential in syngeneic tumor bearing mice. Mol. Oncol. 7(3):475–483 (2013)
  • A. Weng, M. Thakur, B. von Mallinckrodt, F. Beceren-Braun, R. Gilabert-Oriol, B. Wiesner, J. Eichhorst, S. Boettger, M. F. Melzig, H. Fuchs. Saponins modulate the intracellular trafficking of protein toxins. J. Control. Release. 164(1):74–86 (2012)
  • N. Schellmann, H. Panjideh, P. Fasold, D. Bachran, C. Bachran, P. M. Deckert, H. Fuchs. Targeted tumor therapy with a fusion protein of an antiangiogenic human recombinant scFv and yeast cytosine deaminase. J. Immunother. 35(7):570–578 (2012)
  • M. Thakur, K. Mergel, A. Weng, S. Frech, R. Gilabert-Oriol, D. Bachran, M. F. Melzig, H. Fuchs. Real time monitoring of the cell viability during treatment with tumor-targeted toxins and saponins using impedance measurement. Biosens. Bioelectron. 35(1):503–506 (2012)
  • A. Weng, M. Thakur, F. Beceren-Braun, D. Bachran, C. Bachran, S. B. Riese, K. Jenett-Siems, R. Gilabert-Oriol, M. F. Melzig, H. Fuchs. The toxin component of targeted anti-tumor toxins determines their efficacy increase by saponins. Mol. Oncol. 6(3):323–332 (2012)
  • D. Bachran, S. Schneider, C. Bachran, A. Weng, M. F. Melzig, H. Fuchs. The endocytic uptake pathways of targeted toxins are influenced by synergistically acting Gypsophila saponins. Mol. Pharmaceut. 8(6):2262-2272 (2011)

Publikationen 21-30

  • M. Thakur, A. Weng, D. Bachran, S. B. Riese, S. Böttger, M. F. Melzig, H. Fuchs. Electrophoretic isolation of saponin fractions from Saponinum album and their evaluation in synergistically enhancing the receptor-specific cytotoxicity of targeted toxins. Electrophoresis 32(21):3085-3089 (2011)
  • C. Bachran, S. Schneider, S. B. Riese, D. Bachran, R. Urban, N. Schellmann, C. Zahn, M. Sutherland, H. Fuchs. A lysine-free mutant of epidermal growth factor as targeting moiety of a targeted toxin. Life Sci. 88(5-6):226-32 (2011)
  • R. Bleul, D. Bachran, R. Thiermann, A. Bertin, H. Fuchs, M. Maskos. Probing polymersome-protein and -cell interactions: Influence of different end-groups and environments. Macromol. Symp. 309/310:134–140 (2011)
  • A. Weng, M. Thakur, A. Schindler, H. Fuchs, M. F. Melzig. Liquid-chromatographic profiling of Saponinum album (Merck). Pharmazie 66(10):744–746 (2011)
  • C. Hoffmann, C. Bachran, J. Stanke, S. Elezkurtaj, A. M. Kaufmann, H. Fuchs, C. Loddenkemper, A. Schneider, G. Cichon. Creation and characterization of a xenograft model for human cervical cancer. Gynecol. Oncol. 118(1):76–80 (2010)
  • Y. Han, D. Shchukin, J. Yang, C. R. Simon, H. Fuchs, H. Möhwald. Biocompatible protein nanocontainers for controlled drugs release. ACS Nano 4(5):2838–2844 (2010)
  • A. Weng, K. Jenett-Siems, P. Schmieder, D. Bachran, C. Bachran, C. Görick, M. Thakur, H. Fuchs, M. F. Melzig. A convenient method for saponin isolation in tumour therapy. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 878(7–8):713–718 (2010)
  • S. Wu, L. Fischer, N. Gökbuget, S. Schwartz, T. Burmeister, M. Notter, D. Hoelzer, H. Fuchs, I. W. Blau, W. K. Hofmann, E. Thiel. Expression of interleukin 15 in primary adult acute lymphoblastic leukemia. Cancer 116(2):387–392 (2010)
  • D. Bachran, S. Schneider, C. Bachran, R. Urban, A. Weng, M. F. Melzig, C. Hoffmann, A. M. Kaufmann, H. Fuchs. Epidermal growth factor receptor expression affects the efficacy of the combined application of saponin and chimeric toxin on human cervical carcinoma cells. Int. J. Cancer 127(6):1453–1461 (2010)
  • C. Bachran, A. Weng, D. Bachran, S. Riese, N. Schellmann, M. F. Melzig, H. Fuchs. The distribution of saponins in vivo affects their synergy with chimeric toxins against tumours expressing human epidermal growth factor receptors in mice. Br. J. Pharmacol. 159(2):345–352 (2010)

Publikationen 31-40

  • K. Wandzik, C. Zahn, K. Dassler, H. Fuchs. Substantial changes of cellular iron homeostasis during megakaryocytic differentiation of K562 cells. Dev. Growth Differ. 51:555-565 (2009)
  • C. Bachran, H. Dürkop, M. Sutherland, D. Bachran, C. Müller, A. Weng, M. F. Melzig, H. Fuchs. Inhibition of tumor growth by targeted toxins in mice is dramatically improved by Saponinum album in a synergistic way. J. Immunother. 32(7):713–725 (2009)
  • A. Weng, C. Bachran, H. Fuchs, E. Krause, H. Stephanowitz, M. F. Melzig. Enhancement of saporin cytotoxicity by Gypsophila saponins – More than stimulation of endocytosis. Chem. Biol. Interact. 181(3):424–429 (2009)
  • A. Weng, D. Bachran, C. Görick, C. Bachran, H. Fuchs, M. F. Melzig. A simple method for isolation of Gypsophila saponins for the combined application of targeted toxins and saponins in tumor therapy Planta Med. 75(13):1421–1422 (2009)
  • A. Weng, C. Bachran, H. Fuchs, M. F. Melzig. Soapwort saponins trigger clathrin-mediated endocytosis of saporin, a type I ribosome-inactivating protein. Chem. Biol. Interact. 176(2-3):204–211 (2008)
  • H. Panjideh, V. Coelho, J. Dernedde, H. Fuchs, U. Keilholz, E. Thiel, P. M. Deckert. Production of bifunctional single-chain antibody-based fusion proteins in Pichia pastoris supernatants. Bioprocess Biosyst. Eng. 31(6):559-568 (2008)
  • H. Panjideh, V. Coelho, J. Dernedde, C. Bachran , G. J. Förster, J. Franke , P. Fasold, H. Fuchs, E. Thiel, P. M. Deckert. Biodistribution and efficacy of [131I]A33scFv::CDy, a recombinant antibody-enzyme protein for colon cancer. Int. J. Oncol. 32(4):925–930 (2008)
  • J. Ervens, H. Fuchs, V.-T. Niemann, B. Hoffmeister. Pyruvate kinase isoenzyme M2 is not of diagnostic relevance as a markerfor oral cancer. J. Craniomaxillofac. Surg. 36(2):89–94 (2008)
  • C. Hetzel, C. Bachran, R. Fischer, H. Fuchs, S. Barth, M. Stöcker. Small cleavable adapters enhance the specific cytotoxicity of a humanized immunotoxin against CD64-positive acute myeloid leukemia cells. J. Immunother. 31(4):370–376 (2008)
  • A. Weng, M. F. Melzig, C. Bachran, H. Fuchs. Enhancement of saporin toxicity against U937 cells by Gypsophila saponins. J. Immunotoxicol. 5(3):287–292 (2008)

Publikationen 41-50

  • C. Bachran, R. Urban, D. Bachran, R. Tauber, H. Fuchs. Der Nachweis von Diphtherietoxinaktivität durch einen hoch sensitiven colorimetrischen Festphasenassay. Klin. Chem. Mitteilungen 39(4+5):106–114 (2008)
  • C. Bachran, I. Heisler, D. Bachran, K. Dassler, M. F. Melzig, J. Ervens, H. Fuchs. Chimeric toxins inhibit growth of primary oral squamous cell carcinoma cells. Cancer Biol. Ther. 7(2):234–239 (2008)
  • H. Fuchs, C. Bachran, T. Li, I. Heisler, H. Dürkop, M. Sutherland. A cleavable molecular adapter reduces side effects and concomitantly enhances efficacy in tumor treatment by targeted toxins in mice. J. Control. Release 117(3):342–350 (2007)
  • C. Bachran, M. Sutherland, D. Bachran, H. Fuchs. Quantification of diphtheria toxin-mediated ADP-ribosylation in a solid phase assay. Clin. Chem. 53(9):1676–1683 (2007)
  • U. Petrausch, J. Dernedde, V. Coelho, H. Panjideh, D. Frey, H. Fuchs, E. Thiel, P. M. Deckert. A33scFv–green fluorescent protein, a recombinant single-chain fusion protein for tumor targeting. Protein Eng. Des. Sel. 20(12):583–590 (2007)
  • V. Coelho, J. Dernedde, U. Petrausch, H. Panjideh, H. Fuchs, C. Menzel, S. Dübel, U. Keilholz, E. Thiel, P. M. Deckert. Design, construction, and in vitro analysis of A33scFv::CDy, a recombinant fusion protein for antibody-directed enzyme prodrug therapy in colon cancer. Int. J. Oncol. 31(4):951–957 (2007)
  • P. Hebestreit, A. Weng, C. Bachran, H. Fuchs, M. F. Melzig. Enhancement of cytotoxicity of lectins by Saponinum album. Toxicon 47(3):330–335 (2006)
  • C. Bachran, M. Sutherland, I. Heisler, P. Hebestreit, M. F. Melzig, H. Fuchs. The saponin-mediated enhanced uptake of targeted saporin-based drugs is strongly dependent on the saponin’s structure. Exp. Biol. Med. (Maywood) 231(4):412-420 (2006)
  • K. Dassler, M. Zydek, K. Wandzik, M. Kaup, H. Fuchs. Release of the soluble transferrin receptor is directly regulated by binding of its ligand ferri- Transferrin. J. Biol. Chem. 281(6):3297–3304 (2006)
  • I. Heisler, M. Sutherland, C. Bachran, P. Hebestreit, A. Schnitger, M. F. Melzig, H. Fuchs. Combined application of saponin and chimeric toxins drastically enhances the targeted cytotoxicity on tumor cells. J. Control. Release 106(1–2):123–137 (2005)

Publikationen 51-60

  • C. Bachran, I. Heisler, H. Fuchs, M. Sutherland Influence of protein transduction domains on target-specific chimeric proteins. Biochem. Biophys. Res. Commun. 337(2):602–609 (2005)
  • K. Dassler, M. Kaup, R. Tauber, H. Fuchs. Mutational suppression of transferrin receptor shedding can be compensated by distinct metalloproteases acting on alternative sites. FEBS Lett. 536(1–3):25–29 (2003)
  • I. Heisler, J. Keller, R. Tauber, M. Sutherland, H. Fuchs. A cleavable adapter to reduce non-specific cytotoxicity of recombinant immunotoxins. Int. J. Cancer 103(2):277–282 (2003)
  • M. Kaup, K. Dassler, C. Weise, H. Fuchs. Shedding of the transferrin receptor is mediated constitutively by an integral membrane metalloprotease sensitive to tumor necrosis factor a protease inhibitor-2. J. Biol. Chem. 277(41):38494–38502 (2002)
  • M. Kaup, K. Dassler, U. Reineke, C. Weise, R. Tauber, H. Fuchs. Processing of the human transferrin receptor at distinct positions within the stalk region by neutrophil elastase and cathepsin G. Biol. Chem. 383(6):1011–1020 (2002)
  • I. Heisler, J. Keller, R. Tauber, M. Sutherland, H. Fuchs. A colorimetric assay for the quantitation of free adenine applied to determine the enzymatic activity of ribosome-inactivating proteins. Anal. Biochem. 302(1):114–122 (2002)
  • H. Fuchs, R. Geßner. Iodination significantly influences the binding of human transferrin to the transferrin receptor. Biochim. Biophys. Acta 1570(1):19–26 (2002)
  • J. Keller, I. Heisler, R. Tauber, H. Fuchs. Development of a novel molecular adapter for the optimization of immunotoxins. J. Control. Release 74(1–3):259–261 (2001)
  • H. Fuchs, R. Geßner. The result of equilibrium constant calculations strongly depends on the evaluation method used and on the type of experimental errors. Biochem. J. 359(Pt 2):411–418 (2001)
  • H. Fuchs, R. Tauber, R. Geßner. Determination of optimal non-denaturing elution conditions from affinity columns by a solid phase screen. Biotechniques 31(3):584, 586, 588–590, passim. (2001)

Publikationen 61-70

  • G. Orberger, H. Fuchs, R. Geyer, R. Geßner, E. Köttgen, R. Tauber. Structural and functional stability of the mature transferrin receptor from human placenta. Arch. Biochem. Biophys. 386(1):79–88 (2001)
  • S. Porwoll, H. Fuchs, R. Tauber. Characterization of a soluble class I a-mannosidase in human serum. FEBS Lett. 449(2-3):175–178 (1999)
  • H.-J. Terng, R. Geßner, H. Fuchs, U. Stahl, C. Lang. Human transferrin receptor is active and plasma membrane-targeted in yeast. FEMS Microbiol. Lett. 160:61–67 (1998)
  • H. Fuchs, U. Lücken, R. Tauber, A. Engel, R. Geßner. Structural model of phospholipid-reconstituted human transferrin receptor derived by electron microscopy. Structure 6(10):1235–1243 (1998)
  • H. Fuchs, G. Orberger, R. Tauber, R. Geßner. Direct calibration ELISA — a rapid method for the simplified determination of association constants of unlabeled biological molecules. J. Immunol. Meth. 188:197–208 (1995)
  • H. Fuchs, R. Geßner, R. Tauber, R. Ghosh. Functional reconstitution of the human placental transferrin receptor into phospholipid bilayers leads to long tubular structures proceeding from the vesicle surface. Biochemistry 34(18):6196–6207 (1995)
  • D. Steverding, Y.-D. Stierhof, H. Fuchs, R. Tauber, P. Overath. Transferrin-binding protein complex is the receptor for transferrin uptake in Trypanosoma brucei. J. Cell Biol. 131(5):1173–1182 (1995)
  • G. Orberger, R. Geßner, H. Fuchs, B. Volz, E. Köttgen, R. Tauber. Enzymatic modeling of the oligosaccharide chains of glycoproteins immobilized onto polystyrene surfaces. Anal. Biochem. 214:195–204 (1993)
  • H. Fuchs, N. Niesler, A. Trautner, S. Sama, G. Jerz, H. Panjideh, A. Weng Glycosylated triterpenoids as endosomal escape enhancers in targeted tumor therapies Biomedicines 5:14 (2017)
  • H. Fuchs, A. Weng, R. Gilabert-Oriol. Augmenting the efficacy of immunotoxins and other targeted protein toxins by endosomal escape enhancers. Toxins (Basel). 8(7):E200 (2016)

Publikationen 71-80

  • R. Gilabert-Oriol , A. Weng, B. von Mallinckrodt, M. F. Melzig, H. Fuchs, M. Thakur. Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy. Curr Pharm Des. 20(42):6584–6643 (2014)
  • C. Bachran, S. Bachran, M. Sutherland, D. Bachran, H. Fuchs. Preclinical studies of saponins for tumor therapy. In: Recent Advances in Medicinal Chemistry (Eds. Atta-ur-Rahman, M. I. Choudhary, G. Perry), Vol. 1, pp. 272–302, ISBN: 978-1-60805-797-9, Bentham Science Publishers, Bussum, Netherlands (2014)
  • M. Thakur, M. F. Melzig, H. Fuchs, A. Weng. Triterpenoid saponins: Role in targeted anti-cancer therapies. In: Natural Bioactive Molecules: Impacts and Prospects (Ed. G. Brahmachari), Chapter 12, pp. 12.1–12.18, ISBN: 978-1842657805, Alpha Science Intl. Ltd., Oxford, United Kingdom (2013)
  • H. Fuchs, C. Bachran, D. J. Flavell. Diving through membranes: molecular cunning to enforce the endosomal escape of antibodytargeted anti-tumor toxins. Antibodies 2(2):209–235 (2013)
  • M. Thakur, A. Weng, H. Fuchs, V. Sharma, C. S. Bhargava, N. S. Chauhan, V. K. Dixit, S. Bhargava. Rasayana properties of Ayurvedic herbs: Are polysaccharides a major contributor? Carbohydrate Polymers 87(1):3–15 (2012)
  • H. Fuchs. Saporin. In: Encyclopedia of cancer (Ed. M. Schwab), 3rd ed., Article ID: 302766, Chapter ID: 7065, Springer-Verlag Berlin Heidelberg, Germany (2012)
  • H. Fuchs, S. Barth. Ribosome-inactivating proteins. In: Encyclopedia of cancer (Ed. M. Schwab) , 3rd ed., Article ID: 302764, Chapter ID: 7063, Springer-Verlag Berlin Heidelberg, Germany (2012)
  • H. Fuchs, S. Barth. Immunotoxins. In: Encyclopedia of cancer (Ed. M. Schwab) , 3rd ed., Article ID: 302769, Chapter ID: 7068, Springer-Verlag Berlin Heidelberg, Germany (2012)
  • H. Fuchs Zelluläre Zäune überwinden – Tödliche Eiweiße in der Tumortherapie Labor & More, Band 2.12, pp. 12–17, Succidia AG, Darmstadt, Germany (2012)
  • M. Thakur, M. F. Melzig, H. Fuchs, A. Weng. Chemistry and pharmacology of saponins: special focus on cytotoxic properties Botanics: Targets and Therapy 2011(1):19–29 (2011)

Publikationen 81-90

  • H. Fuchs, C. Bachran. Design of targeted protein toxins. In: Drug delivery in oncology – from basic research to cancer therapy (Eds. F. Kratz, P. Senter, H. Steinhagen), pp. 1443–1487. ISBN: 978-3-527-32823-9, Wiley-VCH, Weinheim, Germany (2011)
  • N. Schellmann, P. M. Deckert, D. Bachran, H. Fuchs, C. Bachran. Targeted Enzyme Prodrug Therapies. Mini-Rev. Med. Chem. 10:887–904 (2010)
  • C. Bachran, H. Fuchs. Meeting report on the 2nd Targeted Tumor Therapies. Mol. Cancer Ther. 9(1):17–23 (2010)
  • C. Hetzel, C. Bachran, M. K. Tur, H. Fuchs, M. Stöcker. Improved immunotoxins with novel functional elements. Curr. Pharm. Des. 15(23):2700–2711 (2009)
  • C. Bachran, H. Fuchs (Eds.) Targeted Tumor Therapies. 10 Reviews. ISSN: 1389-4501. Current Drug Targets, Bentham Science Publishers Ltd., Oak Park, Illinois, USA (2009)
  • C. Bachran, H. Fuchs. The Fabisch-Symposium 2009 on targeted tumor therapies Current Drug Targets 10(2):88 (2009)
  • H. Fuchs, C. Bachran Targeted tumor therapies at a glance Current Drug Targets 10(2):89–93 (2009)
  • H. Fuchs, D. Bachran, H. Panjideh, N. Schellmann, A. Weng, M. F. Melzig, M. Sutherland, C. Bachran Saponins as tool for improved targeted tumor therapies Current Drug Targets 10(2):140–151 (2009)
  • C. Bachran, S. Bachran, M. Sutherland, D. Bachran, H. Fuchs. Saponins in tumor therapy. Mini-Rev. Med. Chem. 8(6):575–584 (2008)
  • H. Fuchs (Ed.). Iron Metabolism and Disease. 22 Chapters. ISBN: 978-81-308-0066-0 Research Signpost, Kerala, India (2008)

Publikationen 91-100

  • H. Fuchs, K. Dassler. Generation and function of soluble transferrin receptor 1. In: Iron metabolism and disease. (Ed. H. Fuchs), Chapter 5, pp. 125–150, ISBN: 978-81-308-0066-0. Research Signpost, Fort P.O., Trivandrum-695 023, Kerala, India (2008)
  • H. Fuchs, M. Kaup. Cellular iron uptake by transferrin receptor 1. In: Iron metabolism and disease. (Ed. H. Fuchs), Chapter 10, pp. 241–272, ISBN: 978-81-308-0066-0. Research Signpost, Fort P.O., Trivandrum-695 023, Kerala, India (2008)
  • C. Bachran, M. Sutherland, D. Bachran, H. Fuchs. Patents on immunotoxins and chimeric toxins for the treatment of cancer. Recent Patents Drug Deliv. Formulation 1(2):105–115 (2007)
  • H. Fuchs, C. Bachran, I. Heisler, M. Sutherland. A closer look at protein transduction domains as a tool in drug delivery. Curr. Nanosci. 1(2):117–124 (2005)
  • M. Sutherland, C. Bachran, I. Heisler, H. Fuchs. Techniques for the analyses of immunotoxin activity. Recent research developments in analytical biochemistry 3:1–20. Transworld Research Network, Kerala, India (2003)
  • H. Fuchs. Struktur des humanen Transferrinrezeptors und Bindung seines Liganden Transferrin. Inaugural-Dissertation, Fachbereich Chemie, Freie Universität Berlin, Berlin 1995
  • Zhao X, Zhang K, Daniel P, Wisbrun N, Fuchs H, Fan H. Delayed allogeneic skin graft rejection in CD26-deficient mice. Cell Mol Immunol. 2018 Mar 23. doi:10.1038/s41423-018-0009-z. [Epub ahead of print] PubMed PMID: 29572550.
Ergebnisse filtern
Keine Ergebnisse? Nutzen Sie bitte auch unsere zentrale Suche.

Es werden maximal 10 Suchergebnisse angezeigt. Um weitere Publikationen anzuzeigen, verfeinern Sie bitte Ihre Suche, z. B. durch Eingabe der Jahreszahl oder/und eines Autors. Die in PubMed gelisteten Veröffentlichungen können Sie auch auf einem Blick erhalten, wenn Sie auf den entsprechenden Link oberhalb des Suchfeldes klicken.